Structure/function analysis of p55 tumor necrosis factor receptor and Fas-associated death domain - Effect on necrosis in L929sA cells

被引:28
作者
Boone, E
Vanden Berghe, T
Van Loo, G
De Wilde, G
De Wael, N
Vercammen, D
Fiers, W
Haegeman, G
Vandenabeele, P
机构
[1] Flanders Interuniv Inst Biotechnol, Dept Mol Biol, B-9000 Ghent, Belgium
[2] State Univ Ghent, B-9000 Ghent, Belgium
关键词
D O I
10.1074/jbc.M007166200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor (TNF) induces a typical apoptotic cell death program in various cell lines by interacting with the p55 tumor necrosis factor receptor (TNF-R55), In contrast, triggering of the fibrosarcoma cell line L929sA gives rise to characteristic cellular changes resulting in necrosis, The intracellular domain of TNF-R55 can be subdivided into two parts: a membrane-proximal domain (amino acids 202-325) and a C-terminal death domain (DD) (amino acids 326-413), which has been shown to be necessary and sufficient for apoptosis, Structure/function analysis of TNF-R55-mediated necrosis in L929sA cells demonstrated that initiation of necrotic cell death, as defined by swelling of the cells, rapid membrane permeabilization, absence of nuclear condensation, absence of DNA hypoploidy, and generation of mitochondrial reactive oxygen intermediates, is also confined to the DD, The striking synergistic effect of the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone on TNF-induced necrosis was also observed with receptors solely containing the DD, TNF-R55-mediated necrosis is not affected by the dominant negative deletion mutant of the Fas-associated death domain (FADD-(80-205)) that lacks the N-terminal death effector domain. Moreover, overexpression of FADD-(80-205) in L929sA is cytotoxic and insensitive to CrmA, while the cytotoxicity due to over-expression of the deletion mutant FADD-(1-111) lacking the DD is prevented by CrmA These results demonstrate that the death domain of FADD can elicit an active necrotic cell death pathway.
引用
收藏
页码:37596 / 37603
页数:8
相关论文
共 48 条
  • [1] A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway
    Adam, D
    Wiegmann, K
    AdamKlages, S
    Ruff, A
    Kronke, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 14617 - 14622
  • [2] A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN
    BOLDIN, MP
    VARFOLOMEEV, EE
    PANCER, Z
    METT, IL
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) : 7795 - 7798
  • [3] Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
    Boldin, MP
    Goncharov, TM
    Goltsev, YV
    Wallach, D
    [J]. CELL, 1996, 85 (06) : 803 - 815
  • [4] Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor
    Boone, E
    Vandevoorde, V
    De Wilde, G
    Haegeman, G
    [J]. FEBS LETTERS, 1998, 441 (02) : 275 - 280
  • [5] FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS
    CHINNAIYAN, AM
    OROURKE, K
    TEWARI, M
    DIXIT, VM
    [J]. CELL, 1995, 81 (04) : 505 - 512
  • [6] Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961
  • [7] The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region
    De Vos, K
    Goossens, V
    Boone, E
    Vercammen, D
    Vancompernolle, K
    Vandenabeele, P
    Haegeman, G
    Fiers, W
    Grooten, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) : 9673 - 9680
  • [8] INVOLVEMENT OF AN ICE-LIKE PROTEASE IN FAS-MEDIATED APOPTOSIS
    ENARI, M
    HUG, H
    NAGATA, S
    [J]. NATURE, 1995, 375 (6526) : 78 - 81
  • [9] Fiers W, 1996, J INFLAMM, V47, P67
  • [10] More than one way to die: apoptosis, necrosis and reactive oxygen damage
    Fiers, W
    Beyaert, R
    Declercq, W
    Vandenabeele, P
    [J]. ONCOGENE, 1999, 18 (54) : 7719 - 7730